Annual Drug Patent Expirations for EMERPHED
Emerphed is a drug marketed by Nexus Pharms and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.
This drug has eight patent family members in eight countries.
The generic ingredient in EMERPHED is ephedrine sulfate. One supplier is listed for this compound. Additional details are available on the ephedrine sulfate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
